Showing results (1211-1220 of 16,810) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|August 10, 2000
Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemiaA Wiestner, S A Padosch, N Ghilardi, et al.British Journal of Haematology|August 10, 2000
Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disordersM K Jensen, P de Nully Brown, B V Lund, et al.British Journal of Haematology|August 10, 2000
Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study GroupE Forestier, B Johansson, G Gustafsson, et al.British Journal of Haematology|August 10, 2000
p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndromeV Brito-Babapulle, R Hamoudi, E Matutes, et al.British Journal of Haematology|August 10, 2000
In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignanciesD Aldinucci, D Poletto, V Zagonel, et al.British Journal of Haematology|August 10, 2000
T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cellsM Raitakari, R D Brown, D Sze, et al.British Journal of Haematology|August 10, 2000
Severe pancytopenia triggered by recombinant hepatitis B vaccineJ F Viallard, J M Boiron, M Parrens, et al.British Journal of Haematology|May 8, 1999
Homocysteine levels in polycythaemia vera and essential thrombocythaemiaH Gisslinger, F Rodeghiero, M Ruggeri, et al.British Journal of Haematology|March 23, 1999
Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agentP J van Genderen, F J Prins, J J Michiels, et al.British Journal of Haematology|March 23, 1999
The potential of human mast cell progenitors to differentiate into mature mast cells remains after prolonged culture with flt3 ligand, interleukin-3 or granulocyte-macrophage colony stimulating factorM Hjertson, C Sundström, K Nilsson, et al.Pageof 1,681